ClinConnect ClinConnect Logo
Search / Trial NCT06071572

San Raffaele IBD Biobank

Launched by IRCCS SAN RAFFAELE · Oct 2, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

The San Raffaele IBD Biobank is a research project designed to study inflammatory bowel diseases (IBD) by collecting and storing biological samples and related health information from participants. By gathering this data, researchers aim to improve our understanding of IBD and support future medical research. If you are an adult (18 years or older) diagnosed with IBD, you might be eligible to participate in this study.

As a participant, you will be asked to give permission for your biological samples, such as tissue or blood, to be collected during routine medical visits or surgeries. These samples will be carefully stored and linked to your health information, which will be kept anonymous to protect your privacy. The goal is to create a comprehensive resource that will help advance IBD research. Your involvement could play a vital role in finding new treatments and better understanding this condition.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with IBD (min 18 years)
  • Exclusion Criteria:
  • Patients without IBD

About Irccs San Raffaele

IRCCS San Raffaele is a prestigious research hospital and clinical trial sponsor based in Milan, Italy, renowned for its commitment to advancing medical science through innovative research and high-quality patient care. As an Institute for Research and Healthcare, it specializes in a wide range of therapeutic areas, including oncology, neurology, and cardiology, and is dedicated to translating scientific discoveries into effective clinical practices. With a multidisciplinary team of experts and state-of-the-art facilities, IRCCS San Raffaele plays a pivotal role in conducting rigorous clinical trials that contribute to the development of novel treatments and improve patient outcomes globally.

Locations

Milan, , Italy

Patients applied

TN

1 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported